<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04846543</url>
  </required_header>
  <id_info>
    <org_study_id>DanubeUK3031</org_study_id>
    <nct_id>NCT04846543</nct_id>
  </id_info>
  <brief_title>Bioresorbable Intramedullary Nailing of Forearm Fractures</brief_title>
  <acronym>BRINFF</acronym>
  <official_title>PMCF Study - Verification of Activa IM-Nail™ Safety and Clinical Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Klestil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bioretec Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Danube University Krems</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Activa IM-Nail™ is used in the fixation of forearm fractures with cast to achieve a level&#xD;
      of reduction and stabilisation that is appropriate to the age of the child. The post-market&#xD;
      clinical follow-up study will be performed to identify the residual risk related to&#xD;
      re-fracture and to determine its impact to the risk/benefit ratio of Activa IM-Nail™.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Residual risk related to re-fracture rate will be addressed by this PMCF study. The research&#xD;
      question is, if the re-fracture risk with Activa IM-nail is in line with the other treatment&#xD;
      methods, namely ESIN.&#xD;
&#xD;
      Primary objective: will be to assess clinical outcome by determining re-fracture rate of all&#xD;
      treated patients, difference of re-fracture rate depending on the fracture type determined by&#xD;
      X-ray (e.g. greenstick vs. non-greenstick fracture), subject's age, BMI, surgical technique,&#xD;
      immobilization time and bony union formation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Refracture rate</measure>
    <time_frame>First year after operation</time_frame>
    <description>Assessment of refracture rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absorption of implant</measure>
    <time_frame>One and two years after operation</time_frame>
    <description>MRI scans are performed to evaluate soft tissue reaction and biodegradability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bony union</measure>
    <time_frame>One year after operation</time_frame>
    <description>Bony union depending on fracture type and immobilization time, return to sport</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monteggia lesion and equivalent</measure>
    <time_frame>2 years after operation</time_frame>
    <description>Safety and performance of operative technique in Monteggia´s lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness</measure>
    <time_frame>1 year after operation</time_frame>
    <description>HTA assessment for different health care systems in Europe</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Forearm Fracture</condition>
  <arm_group>
    <arm_group_label>MRI scan 1st and 2nd year</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Additionally to routinely follow up, there will be an MRI scan of enrolled patients after one and two years in some of the study sites</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI Scan</intervention_name>
    <description>MRI scan</description>
    <arm_group_label>MRI scan 1st and 2nd year</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diaphyseal forearm fractures (radius or ulna or both)&#xD;
&#xD;
          -  Patients from 3 years to under 13 years, but the age limits depend on the biological&#xD;
             development of the child and in addition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  multifragmentary fractures, metaphyseal and epiphyseal fractures&#xD;
&#xD;
          -  Situations where internal fixation is otherwise contraindicated, e.g., active or&#xD;
             potential infection, or where a patient's cooperation cannot be guaranteed.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Roeder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Landesklinikum Baden/Moedling</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christoph Roeder, MD</last_name>
    <phone>+4322529004</phone>
    <phone_ext>27166</phone_ext>
    <email>christoph.roeder@moedling.lknoe.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Klestil, MD</last_name>
    <phone>+4322529004</phone>
    <phone_ext>13201</phone_ext>
    <email>thomas.klestil@moedling.lknoe.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Landesklinikum Moedling</name>
      <address>
        <city>Mödling</city>
        <state>Lower Austria</state>
        <zip>2340</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Roeder, MD</last_name>
      <phone>+4322529004</phone>
      <phone_ext>27166</phone_ext>
      <email>christoph.roeder@moedling.lknoe.at</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Klestil, MD</last_name>
      <phone>+4322529004</phone>
      <phone_ext>13201</phone_ext>
      <email>thomas.klestil@moedling.lknoe.at</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Herlev and Gentofte University Hospital Department of Orthopedic Surgery</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Morten Andersen</last_name>
      <phone>+ 45 38 68 14 79</phone>
      <email>morten.jon.andersen@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hvidovre Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louise Klingenberg</last_name>
      <phone>0045 40884943</phone>
      <email>louise.klingenberg.03@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lille University Center, Jeanne de Flandre Hospital</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Federico Canavese, Prof.</last_name>
      <phone>+33 3 20 44 68 67</phone>
      <email>federico.canavese@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Schleswig-Holstein, Campus Lübeck Department of Pediatric Surgery</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ludger Tüshaus</last_name>
      <phone>+49 451 500 42611</phone>
      <email>ludger.tueshaus@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Péterfy Hospital, National Trauma Center, Department of Pediatric Trauma Surgery</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcell Varga</last_name>
      <phone>0036 79 932 30 27</phone>
      <email>drvmarcell@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pécs University Hospital, Department of Pediatrics</name>
      <address>
        <city>Pécs</city>
        <zip>7623</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gergo Jozsa</last_name>
      <phone>+3672/535-900</phone>
      <email>dr.jozsa.gergo@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Pediátrico - CHUC, EPE</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-602</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristina Alves</last_name>
      <phone>+351239480355</phone>
      <email>6443@chuc.min-saude.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <zip>1010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Lutz</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Portugal</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Korhonen L, Perhomaa M, Kyrö A, Pokka T, Serlo W, Merikanto J, Sinikumpu JJ. Intramedullary nailing of forearm shaft fractures by biodegradable compared with titanium nails: Results of a prospective randomized trial in children with at least two years of follow-up. Biomaterials. 2018 Dec;185:383-392. doi: 10.1016/j.biomaterials.2018.09.011. Epub 2018 Sep 11.</citation>
    <PMID>30292588</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Danube University Krems</investigator_affiliation>
    <investigator_full_name>Thomas Klestil</investigator_full_name>
    <investigator_title>Univ.-Prof. DDr. Thomas Klestil</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

